Zealand Pharma A (ZEAL) Return on Investment ROI from the fourth quarter of 2021 to fourth quarter of 2020 and for the year 2021, average high and low, overall ranking from Dec 31 2021 to Sep 30 2020 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Zealand Pharma A  (NASDAQ: ZEAL)


Zealand Pharma A's ROI from its fourth quarter of 2021 to the fourth quarter of 2020 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Zealand Pharma A's ROI in the fourth quarter of 2021?
Zealand Pharma A recorded a cumulative net loss of $-162 million during 12 months ending in the fourth quarter of 2021, resulting in a negative return on investment (ROI) of -13.24%.

Within the Healthcare sector 478 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2021 from to 4563.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2021)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Sep 30 2020)
III. Quarter
Y / Y Investment Change TTM 448.75 % 487.05 % 485.85 % 384.45 % 229.65 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 633 1,420 1,420 1,420 231
Return On Investment (TTM) -13.24 % -3.2 % -6.31 % -9.87 % -23.68 %
ZEAL's Overall Ranking # 4563 # # # # 4586
Seq. Investment Change TTM 8.95 % 34.09 % 56.48 % 140.03 % 16.56 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -162 -36 -53 -53 -53

ZEAL Company Profile >> Back to ZEAL Roi Comparisons >> See Annual ZEAL Return On Investment



Return On Investment ZEAL's Ranking
Within: No.
Industry # 179
Sector # 479
Overall # 4563

Return On Investment Statistics
High Average Low
53.81 %
-16.5 %
-56.06 %
(Dec 31 2018)   (Dec 31 2020)







Financial Statements
Zealand Pharma A's IV. Quarter Investments $ 633 Millions ZEAL's Balance sheet
Zealand Pharma A's IV. Quarter Income $ -162 Millions Quarterly ZEAL's Income Statement
ZEAL's Income by Division See ZEAL's Income by Division


ZEAL Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2015)
2017
Total Investments in Millions 633 231 211 171 129
Y / Y Investment Growth 173.83 % 9.57 % 23.19 % 33.15 % -
Net Income in Millions -162 -130 -86 92 -42
Y / Y Net Income Growth - - - - -
Annual Return On Investment -25.58 % -56.06 % -40.61 % 53.81 % -32.51 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ZEAL's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ZEAL's Competitors
Subscribers only: Roi for Zealand Pharma A's Suppliers
Subscribers only: Return On Investment for ZEAL's Customers

Other Ratios
ZEAL's Roa ZEAL's Inventory Turnover Ratio ZEAL's Growth Rates ZEAL's Dividend Statistics
ZEAL's Profitability Ratios ZEAL's Asset Turnover Ratio ZEAL's Dividend Growth
ZEAL's Roe ZEAL's Valuation Ratios ZEAL's Financial Strength Ratios ZEAL's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2021, within Healthcare Sector ROI

Date modified: 2026-09-09T12:37:48+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.